"Misión. Contribuir al desarrollo científico y tecnológico con el objeto de aportar nuevos conocimientos en las áreas que conforman la pediatría, formar recursos humanos de excelencia que se dediquen al cuidado de la salud de la niñez mexicana y brindar atención médico-quirúrgica de elevada complejidad a la población infantil y adolescente."

During the past decade, Instituto Nacional de Pediatria conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 12 clinical trials were completed, i.e. on average, 48% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Nacional de Pediatria" #1 sponsor was "Shire" with 4 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Takeda" with 3 trials sponsored, "H. Lundbeck A/S" with 2 trials sponsored and "Merck Sharp & Dohme LLC" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Nacional de Pediatria" #1 collaborator was "Abogen Biosciences Co. Ltd." with 1 trials as a collaborator, "EPIC Research CRO" with 1 trials as a collaborator, "Ferrer Laboratories" with 1 trials as a collaborator, "ILS Clinical Research" with 1 trials as a collaborator and "Mexican Emerging Infectious Diseases Clinical Research Network" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Nacional de Pediatria" are "Hunter Syndrome" (3 trials), "COVID-19" (2 trials), "Depressive Disorder, Major" (2 trials), "Asthma" (1 trials) and "Complicated Intra-Abdominal Infection" (1 trials). Many other conditions were trialed in "Instituto Nacional de Pediatria" in a lesser frequency.

Most popular intervention types in "Instituto Nacional de Pediatria" are "Drug" (21 trials), "Biological" (7 trials), "Other" (3 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Ceftolozane/Tazobactam" (2 trials), "Meropenem" (2 trials), "Ataluren" (1 trials) and "Baricitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Nacional de Pediatria" are 25 trials for "All" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Instituto Nacional de Pediatria". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Instituto Nacional de Pediatria, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Nacional de Pediatria, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".